Analyst Ranking
Bottom 7%
#4547 out of 4870 analysts
Average Return
-12.26%
Win Rate
25%15 out of 59
Risk vs Reward
Poor
Good

Mason Carrico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Caredx IncCDNA
+228.02%$7.21$23.65
2023-11-08 -
2024-11-08
Strong Buy
Natera IncNTRA
+154.88%$66.00$168.22
2024-01-29 -
2025-01-29
Strong Buy
Natera IncNTRA
+149.63%$67.50$168.50
2024-01-16 -
2025-01-16
Strong Buy
Caredx IncCDNA
+120.05%$8.28$18.22
2024-04-16 -
2025-04-16
Strong Buy
Guardant Health IncGH
+91.50%$25.52$48.87
2024-05-23 -
2025-05-01
Strong Buy

Mason Carrico Analyst Color

Get additional color on Mason Carrico's coverage of popular stocks

Mason Carrico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Veracyte IncVCYT
4Strong Buy$45.00+51.46%Reiterates
a month ago
Oncocyte CorpOCX
4Hold$4.00+29.03%Reiterates
a month ago
Guardant Health IncGH
5Strong Buy$55.00+12.54%Reiterates
a month ago
Akoya Biosciences IncAKYA
6Hold$1.80+48.76%Downgrades
a month ago
Cytek Biosciences IncCTKB
2Strong Buy$6.00+62.16%Reiterates
a month ago
Staar Surgical CoSTAA
2Hold$17.00-7.31%Reiterates
a month ago
Illumina IncILMN
7Strong Buy$156.00+103.89%Reiterates
2 months ago
Establishment Labs Holdings IncESTA
2Strong Buy$52.00+67.53%Reiterates
2 months ago
Caredx IncCDNA
9Strong Buy$40.00+165.43%Reiterates
2 months ago
Pacific Biosciences Of California IncPACB
3Strong Buy$2.50+125.23%Reiterates
2 months ago
Hologic IncHOLX
3Strong Buy$84.00+46.65%Reiterates
3 months ago
Paragon 28 IncFNA
1Hold$13.00-0.69%Downgrades
3 months ago
Myriad Genetics IncMYGN
4Hold$20.00+180.50%Reiterates
4 months ago
Vericel CorpVCEL
1Strong Buy$65.00+71.41%Reiterates
4 months ago
Castle Biosciences IncCSTL
7Strong Buy$41.00+112.33%Reiterates
4 months ago
10x Genomics IncTXG
5Strong Buy$30.00+270.37%Reiterates
7 months ago
Natera IncNTRA
4Strong Buy$125.00-17.42%Reiterates
9 months ago
Neogenomics IncNEO
1Strong Buy$19.00+161.71%Reiterates
9 months ago
Dermtech IncDMTKQ
4Hold$1.50N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.